We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
You may need to tell DVLA if you have diabetes, depending on the treatment you're getting
Sets out the government's quality standards for diabetes services.
Report diabetes treated with insulin to DVLA if you're a lorry, bus or coach driver.
The new presentation of Mounjaro gives four doses for once-a-week treatment over a month.
Employment Appeal Tribunal Judgment of Lord Fairley on 18 April 2024.
Employment Appeal Tribunal Judgment of Mrs Justice Eady on 18 April 2024.
Employment Appeal Tribunal Judgment of Judge Tayler on 12 April 2024.
A statement from the Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment (COC).
Falsified, potentially harmful Ozempic▼ and Saxenda products have been found in the UK.
Calculate nutrient budgets for developments in the catchment of Lindisfarne SPA.
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
Check the tariff classification for peptide nisin standardised with sodium chloride
Letter from Dr Rowan Hillson.
For the first time in the UK, obese patients and people who are overweight with weight-related health problems could now have access to Mounjaro, currently used for Type 2 diabetes, to help manage their weight and support weight loss.
Fresenius Kabi Limited has informed the MHRA of an error on the infusion bag packaged into the specific batches of Sodium Chloride Intravenous Infusion 0.9% Freeflex.
Check the tariff classification for surface-active preparation for washing the skin and the hair (gel 2-in-1).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.